오리엔트바이오
1,288KRWMarket close of 10/28 (Wed)
Down -0.69%-9KRWMarket close of 10/28 (Wed)
- Open
- 1,283
- High
- 1,330
- Low
- 1,280
- Day range
- Day range low 1,280 high 1,330, open 1,283, close 1,288, previous close 1,297
- Volume
- 2×10K shares
- 29.73 million KRW 0.32× the 20-session average
Market close of 10/28 (Wed)
Free · no sign-inSource from 2021-05-17
Points to check
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
- Daily moveusual range-0.69%-0.69%, 0.3× the usual (20-session average ±2.43%)That day -0.69% · usual ±2.43% · large-move threshold ±4.9%
The other 2 are within the usual range
- Trading value0.3×usual range
- EarningsOperating income, 4 quarters
With 22 trading days, the 1-year position isn't calculated · First data date 9/22 (Tue)
See the full check report
Quarterly results · Q4 2021
- Revenue6.8B KRW
- vs. year ago
- —
- vs. prior quarter
- -60.3%
- Operating income571.28 million KRW
- vs. year ago
- —
- vs. prior quarter
- -43.6%
- Operating margin8.4%
- vs. year ago
- —
- vs. prior quarter
- +2.5 pp
This quarter is derived: annual results minus Q1–Q3.
Quarterly operating income trend
As of the latest official close · 2026-10-28Valuation filing date · 2022-02-14Same sector · 제약
Up +0.44%· 100 of 169 stocks up, preferred shares excluded · trading value 566.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 셀트리온 | Close over the last 20 sessions +6.1% | Up +0.64% | 80.0B KRW |
| 삼성바이오로직스 | Close over the last 20 sessions -0.9% | Down -0.15% | 68.9B KRW |
| 파마리서치 | Close over the last 20 sessions -27.8% | Down -1.30% | 43.9B KRW |
| 한미약품 | Close over the last 20 sessions -27.1% | Up +5.42% | 42.3B KRW |
| 삼익제약 | Close over the last 20 sessions -13.1% | Up +9.54% | 34.5B KRW |
Schedule
- Next data 10/30 (Fri) after 08:50
Related news
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 83% of trading value, about 93% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.